Related Experiment Video
Updated: Aug 8, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
Regulation of Nrf2 transactivation domain activity by p160 RAC3/SRC3 and other nuclear co-regulators
Wen Lin1, Guoxiang Shen, Xiaoling Yuan
1Department of Pharmaceutics, Ernest-Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, 08854, USA.
Abstract:
Transcription factor NF-E2-related factor 2 (Nrf2) regulates the induction of Phase II detoxifying enzymes and antioxidant enzymes in response to many cancer chemopreventive compounds. In this study, we investigated the role of receptor associated coactivator (RAC3) or steroid receptor coactivator-3 (SRC3) and other nuclear co-regulators including CBP/p300 (CREB-binding protein), CARM1(Coactivator-associated arginine methyltransferase), PRMT1(Protein arginine methyl-transferase 1), and p/CAF (p300/CBP-associated factor) in the transcriptional activation of a chimeric Gal4-Nrf2-Luciferase system containing the transactivation domain (TAD) of Nrf2 in HepG2 cells. The results indicated that RAC3 up-regulated the transactivation activity of Gal4-Nrf2-(1-370) in a dose-dependent manner. The enhancement of transactivation domain activity of Gal4-Nrf2-(1-370) by RAC3 was dampened in the presence of dominant negative mutants of RAC3. Next we studied the effects of other nuclear co-regulators including CBP/ p300, CARM1, PRMT1 and p/CAF, and the results showed that they had different level of positive effects on this transactivation domain activity of Gal4-Nrf2-(1-370). But importantly, synergistic effects of these co-regulators in the presence of RAC3/SRC3 on the transactivation activity of Gal4-Nrf2-(1-370) were observed. In summary, our present study showed for the first time that the 160 RAC3/SRC3 is involved in the functional transactivation of TAD of Nrf2 and that the other nuclear co-regulators such as CBP/p300, CARM1, PRMT1 and p/CAF can also transcriptionally activate this TAD of Nrf2 and that they could further enhance the transactivation activity mediated by RAC3/SRC3.
Insights
Receptor associated coactivator 3 (RAC3/SRC3) and other nuclear co-regulators enhance the transcriptional activity of Nrf2. These co-regulators, including CBP/p300, CARM1, PRMT1, and p/CAF, show synergistic effects with RAC3/SRC3 in activating Nrf2 transactivation.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor crucial for cellular defense against oxidative stress and detoxification.
- Nrf2 regulates the expression of Phase II detoxifying and antioxidant enzymes, playing a vital role in cancer chemoprevention.
- Understanding the co-regulators involved in Nrf2 transcriptional activation is essential for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the role of receptor associated coactivator 3 (RAC3/SRC3) in the transcriptional activation of Nrf2.
- To examine the involvement of other nuclear co-regulators, including CBP/p300, CARM1, PRMT1, and p/CAF, in Nrf2 transactivation.
- To determine the synergistic effects of RAC3/SRC3 with other co-regulators on Nrf2 transcriptional activity.
Main Methods:
- Utilized a chimeric Gal4-Nrf2-Luciferase system in HepG2 cells to assess Nrf2 transactivation.
- Investigated the dose-dependent effect of RAC3/SRC3 on the transactivation domain (TAD) of Nrf2.
- Examined the impact of dominant-negative RAC3 mutants on Nrf2 transactivation.
- Assessed the individual and combined effects of CBP/p300, CARM1, PRMT1, and p/CAF on Nrf2 TAD activity.
Main Results:
- RAC3/SRC3 significantly up-regulated the transactivation activity of the Nrf2 TAD in a dose-dependent manner.
- Dominant-negative RAC3 mutants diminished the enhancement of Nrf2 TAD activity by RAC3.
- CBP/p300, CARM1, PRMT1, and p/CAF demonstrated varying degrees of positive effects on Nrf2 TAD activity.
- Synergistic transcriptional activation of Nrf2 TAD was observed when RAC3/SRC3 was combined with other nuclear co-regulators.
Conclusions:
- RAC3/SRC3 is a key player in the functional transactivation of the Nrf2 TAD.
- Nuclear co-regulators CBP/p300, CARM1, PRMT1, and p/CAF can independently activate Nrf2 TAD.
- These co-regulators can further potentiate the Nrf2 transactivation activity mediated by RAC3/SRC3, highlighting a complex regulatory network.
Related Concept Videos
Regulation of Nuclear Protein Sorting
Co-activators and Co-repressors
Co-activators and Co-repressors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Master Transcription Regulators
Master Transcription Regulators
